Davis Matthew W.
SEC CIK 2094283 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | Chief Development Off | 100.0K | — | — | 2 | 2025-11-10 | 2026-03-09 |
Most active insiders at AQST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barber Daniel | Pres, CEO, Dir | — | $1.77M |
| 2 | Jung Cassie | COO | — | $664.6K |
| 3 | Boyd Peter E. | See Remarks | — | $257.3K |
| 4 | TOTH A ERNEST JR | CFO | — | $242.9K |
| 5 | BRAENDER LORI J | Corp. Sec | — | $167.2K |
| 6 | Kraus Carl N | Chief Medical Off | — | $141.9K |
| 7 | Krop Julie | Dir | — | $125.4K |
| 8 | Korczynski Sherry | Chief Commercial Off | — | $111.3K |
| 9 | Cioffi Melina | SVP, Regulatory Affairs | — | $105.5K |
| 10 | Zalewski Thomas A. | CLO | — | — |
| 12 | Davis Matthew W. | Chief Development Off | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-11 | 2026-03-09 | AQST | Aquestive Therapeutics, Inc. | Davis Matthew W. | Chief Development Off | A - Grant | $0.00 | +50.0K | 100.0K | +100% | $0 |
| D | 2025-11-12 | 2025-11-10 | AQST | Aquestive Therapeutics, Inc. | Davis Matthew W. | Chief Development Off | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations